Laird Norton Wetherby Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $400K | Buy |
|
|||||
|
2024
Q4 | $270K | Sell |
|
|||||
|
2024
Q3 | $372K | Buy |
|
|||||
|
2024
Q2 | $279K | Sell |
|
|||||
|
2024
Q1 | $216K | Sell |
|
|||||
|
2023
Q4 | $311K | Buy |
|
|||||
|
2023
Q3 | $230K | Sell |
|
|||||
|
2023
Q2 | $295K | Buy |
|
|||||
|
2023
Q1 | $273K | Sell |
|
|||||
|
2022
Q4 | $353K | Sell |
|
|||||
|
2022
Q3 | $338K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $214K | Buy |
|
|||||
|
2021
Q4 | $222K | Buy |
|
|||||
|
2021
Q3 | $238K | Buy |
|
|||||
|
2021
Q2 | $205K | Buy |
|